Part 1: Pre-Assessment Survey

  1. In an effort to better serve the needs of people with cancer and their loved ones, we are asking you to complete several questions that will be used to evaluate and improve this educational program on clinical trials. The information you provide may be written into a published report, though we will not reveal your identity or personal information. Please confirm that you understand this statement of consent and still would like to voice your opinion:
 
  2. Please enter a name or 'id' that is unique to you. You will be asked to enter this same name when completing the Post-Assessment Survey as well. We STRONGLY recommend that you use your email address. Please note that NO email will be sent to you and your email address will not be shared with anyone else. *THIS IS A REQUIRED FIELD.
 
  3. Please tell us who you are:
 
  4. Your age:
 
  5. Your gender:
 
  6. Your highest level of education:
 
  7. Your ethnicity:
 
  8. Would you descibe yourself as:
 
  9. If you or a loved one has cancer, what is the type of cancer?
 
  10. How long since diagnosis?
 
  11. Are you or your loved one currently receiving treatment for cancer?
 
  12. Who has talked with you or your loved one about clinical trials? (Select all that apply. Window users must hold down control or shift while selecting multiple answers.)
 
  13. Which response most closely represents your experience or your loved one's experience with clinical trials? (select one):
 
  14. Have you received information about clinical trials in the past?
 
  15. If yes to the last question, please check all that apply. (Window users must hold down control or shift while selecting multiple answers.)
 
  16. If you received information about clinical trials at a workshop or educational forum, please list where:
 
  17. How do you prefer to receive information on this topic? (Select all that apply. Window users must hold down control or shift while selecting multiple answers.)
 
  18. If you or your loved one would not like to participate in a clinical trial, why not? (Select all that apply. Window users must hold down control or shift while selecting multiple answers.)
 
  19. Do you know how to find a trial that might be appropriate for you or your loved one's cancer?
 
  20. If yes, where?
 
  21. At this time, do you feel anxious about participating in a clinical trial?
 
Please rate your answer to the following questions on a scale of 1-5, with 1 being the lowest score and 5 being the highest score.
  22. How would you rate your current knowledge of clinical trials?
 
  23. How would you rate your (or your loved one's) willingness to participate in a clinical trial?
 
Please respond True or False to each of the following statements:
  24. Placebos (sugar pills) are almost never used in cancer treatment trials but may be used in cancer prevention trials:
 
  25. Clinical trials are usually the "last resort" for patients who have no other treatment choices.
 
  26. In randomized trials, participants are assigned to either a control group or the study group by an objective panel of scientists.
 
  27. Usually, the longest part of the drug development process is finding people to participate in the clinical trial.
 
  28. If new benefits, risks, or side effects are discovered during a trial, the researcher is not obligated to tell study participants.
 
  29. A clinical trial cannot be stopped before the study has been completed because of the high cost of conducting research.
 
  30. Most cancer patients know about clinical trials but prefer not to participate.
 
  31. One reason why people do not participate in clinical trials is a general fear or distrust of research.
 
  32. Doctors discuss clinical trials as a treatment option to racially and ethnically diverse populations because they are more likely to be medically underserved.
 
  33. In most clinical trials, patients receive free care.
 
  34. Extra tests may be required in a clinical trial that a patient's health plan may not cover.
 
  35. The physician who makes the cancer diagnosis always informs the patient of available clinical trials.
 
powered by phpQuestionnaire